Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Opdualag (nivolumab / relatlimab)
- poliovirus vaccine, live, trivalent
Interactions between your drugs
poliovirus vaccine, live, trivalent nivolumab
Applies to: poliovirus vaccine, live, trivalent, Opdualag (nivolumab / relatlimab)
If you are currently being treated or are going to begin treatment with nivolumab, you should let your doctor know before receiving poliovirus vaccine, live, trivalent. You may be at risk for developing an infection from poliovirus vaccine, live, trivalent or have a reduced response to poliovirus vaccine, live, trivalent, although this has not been studied. If you have recently received poliovirus vaccine, live, trivalent, your doctor may choose to postpone treatment with nivolumab for a few weeks, or you may need to wait for a period of time after completing your treatment with nivolumab before receiving poliovirus vaccine, live, trivalent. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Tecentriq Hybreza
Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) is a subcutaneous formulation of Tecentriq ...
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Proleukin
Proleukin is used for melanoma, melanoma, metastatic, renal cell carcinoma
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.